NASDAQ

Eledon Pharmaceuticals, Inc. (ELDN)

♥ 661 Thanks from members

Live price chart, market sentiment, and community perspectives for Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Eledon PharmaceuticalsLeadership: David Perry (CEO)Holder: Perceptive AdvisorsHolder: RA Capital ManagementHolder: Vanguard Group Inc.TegoprubartANB020#ELDN#Eledon Pharmaceuticals#Biotech#Immunology#Transplantation Therapeutics